#160703

HeLa pCDH-CMV-MCS-EF1-copGFP Control Cell Line

Cat. #160703

HeLa pCDH-CMV-MCS-EF1-copGFP Control Cell Line

Cat. #: 160703

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Peter Bradding ; Harvinder Virk

Institute: University of Leicester

Tool Details
Target Details
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: HeLa pCDH-CMV-MCS-EF1-copGFP Control Cell Line
  • Research fields: Neurobiology
  • Tool sub type: Continuous
  • Parental cell: HeLa cervical cancer cell line
  • Conditional: No
  • Description: This cell line is a negative control for the TRPA1 and TRPM2 cell lines developed by Prof Peter Bradding and Dr Harvinder Virk at University of Leicester (see Related tab). This HeLa cell line is stably transfected with the dual-gene promotor pCDH-CMV-MCS-EF1-copGFP vector without carrying a gene of interest.

Target Details

  • Target: GFP

Handling

  • Format: Frozen
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: Transient receptor potential ankyrin 1 (TRPA1)-GFP HeLa cell line ; Transient receptor potential cation channel superfamily M member 2 (TRPM2)-GFP HeLa cell line

References

  • Virk et al. 2019. Sci Rep. 9(1):18500. PMID: 31811235.